The company’s custom implants compete with devices from Medtronic, Johnson & Johnson and Globus Medical.

The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA said.

Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at ...

The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed ...

J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the ...

The orthopedics firm is looking to round out its robotics offerings with the planned $177 million acquisition. Some analysts ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

Meanwhile, Brazil announced its own countermeasures while Mexico remains confident it will reach a deal by Aug. 1.

What We’re Reading Industry reads hand-picked by our editors ...

The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots ...